ReviewFrontiers in oncology2018

Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.

Timothy M Pierpont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.